Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.
about
Diffusion-Weighted MRI Reflects Proliferative Activity in Primary CNS Lymphoma.Stereotactic ablative body radiotherapy for primary kidney cancer: what have we learned from prospective trials and what does the future hold?Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI.Multiparametric MR diffusion-weighted imaging for monitoring the ultra-early treatment effect of sorafenib in human hepatocellular carcinoma xenografts.Incremental Value of Magnetic Resonance Imaging in Further Characterizing Hypodense Mediastinal and Paracardiac Lesions Identified on Computed Tomography.
P2860
Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Assessment of early therapeuti ...... diffusion-weighted MR imaging.
@en
type
label
Assessment of early therapeuti ...... diffusion-weighted MR imaging.
@en
prefLabel
Assessment of early therapeuti ...... diffusion-weighted MR imaging.
@en
P2093
P2860
P356
P1476
Assessment of early therapeuti ...... diffusion-weighted MR imaging.
@en
P2093
P2860
P304
P356
10.1259/BJR.20150163
P407
P577
2015-07-02T00:00:00Z